LCD L36021: MolDX: Molecular Diagnostic Tests (MDT) — CGS
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
Code intelligence
0090U reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code 0090U.
Elevated code risk
Signal breakdown
6 shown · 6 total in platform
Risk: Elevated
0
Critical
0%
6
High
100%
0
Routine
0%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L39373: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma — Noridian
Policy LCD-L39373 · Dermatology
New billing codes for melanoma testing effective Jan 2026.
LCD L39389: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma — CGS
Policy LCD-L39389 · Oncology
New LCD impacts melanoma molecular assay billing.
LCD L39375: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma — Noridian
Policy LCD-L39375 · Oncology
New LCD affects billing for melanoma molecular assays.
LCD L36256: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L36256 · Clinical Laboratory
New molecular diagnostics policy may impact billing processes.
LCD L35160: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
Audit documentation
Building an audit file that includes 0090U?
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription